De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Art Vivant Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Art Vivant heeft een totaal eigen vermogen van ¥16.0B en een totale schuld van ¥11.2B, wat de schuld-eigenvermogensverhouding op 70% brengt. De totale activa en totale passiva bedragen respectievelijk ¥34.5B en ¥18.4B. De EBIT Art Vivant is ¥2.0B waardoor de rentedekking -34 is. Het heeft contanten en kortetermijnbeleggingen van ¥4.4B.

Belangrijke informatie

70.0%

Verhouding schuld/eigen vermogen

JP¥11.23b

Schuld

Rente dekkingsratio	-34x
Contant	JP¥4.41b
Aandelen	JP¥16.03b
Totaal verplichtingen	JP¥18.43b
Totaal activa	JP¥34.46b

Recente financiële gezondheidsupdates

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

Feb 08

Recent updates

Additional Considerations Required While Assessing Art Vivant's (TSE:7523) Strong Earnings

May 22

How Much Did Art Vivant's(TYO:7523) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 15

Are Art Vivant's (TYO:7523) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 27

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥29.2B ) 7523 } overtreffen de korte termijn passiva ( ¥16.4B ).

Langlopende schulden: De kortetermijnactiva 7523 ( ¥29.2B ) overtreffen de langetermijnschulden ( ¥2.0B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 42.5% ) 7523 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 7523 is de afgelopen 5 jaar gestegen van 48.8% naar 70%.

Schuldendekking: De operationele kasstroom van 7523 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: 7523 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Art Vivant Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

Recent updates

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 1,500,000 shares, representing 14.57% for ¥1,525.5 million.

Upcoming dividend of JP¥30.00 per share

Art Vivant Co., Ltd. to Report Q2, 2025 Results on Nov 13, 2024

First quarter 2025 earnings released: EPS: JP¥46.50 (vs JP¥70.67 in 1Q 2024)

Investor sentiment deteriorates as stock falls 17%

Full year 2024 earnings released: EPS: JP¥164 (vs JP¥124 in FY 2023)

Additional Considerations Required While Assessing Art Vivant's (TSE:7523) Strong Earnings

Full year 2024 earnings released: EPS: JP¥164 (vs JP¥124 in FY 2023)

Art Vivant Co., Ltd., Annual General Meeting, Jun 24, 2024

Upcoming dividend of JP¥30.00 per share

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 550,000 shares, representing 5.14% for ¥652.3 million.

Art Vivant Co., Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: JP¥37.39 (vs JP¥57.70 in 3Q 2023)

Art Vivant Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥36.22 (vs JP¥41.68 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 300,000 shares, representing 2.76% for ¥369 million.

Upcoming dividend of JP¥30.00 per share at 2.5% yield

Art Vivant Co., Ltd. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥70.66 (vs JP¥29.66 in 1Q 2023)

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 150,000 shares, representing 1.37% for ¥150 million.

Art Vivant Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: EPS: JP¥124 (vs JP¥107 in FY 2022)

Investor sentiment improves as stock rises 17%

Upcoming dividend of JP¥15.00 per share at 4.8% yield

Third quarter 2023 earnings released: EPS: JP¥57.69 (vs JP¥35.11 in 3Q 2022)

Art Vivant Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 300,000 shares, representing 2.72% for ¥200 million.

Second quarter 2023 earnings released: EPS: JP¥41.67 (vs JP¥40.04 in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: EPS: JP¥41.67 (vs JP¥40.04 in 2Q 2022)

Upcoming dividend of JP¥15.00 per share

Art Vivant Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: JP¥29.66 (vs JP¥38.41 in 1Q 2022)

Art Vivant Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Art Vivant Co., Ltd., Annual General Meeting, Jun 24, 2022

No independent directors

Art Vivant Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥15.00 per share

Second quarter 2022 earnings released: EPS JP¥41.52 (vs JP¥20.12 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥41.32 (vs JP¥1.90 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥55.32 (vs JP¥99.79 in FY 2020)

Art Vivant's (TYO:7523) Returns On Capital Are Heading Higher

Upcoming dividend of JP¥15.00 per share

Should Art Vivant (TYO:7523) Be Disappointed With Their 63% Profit?

Art Vivant Co., Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JP¥42.58 (vs JP¥33.29 in 3Q 2020)

New 90-day high: JP¥585

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

New 90-day high: JP¥550

Is Art Vivant (TYO:7523) A Future Multi-bagger?

Would Art Vivant Co., Ltd. (TYO:7523) Be Valuable To Income Investors?

How Much Did Art Vivant's(TYO:7523) Shareholders Earn From Share Price Movements Over The Last Three Years?

Art Vivant Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Are Art Vivant's (TYO:7523) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Second quarter 2021 earnings released: EPS JP¥20.12

Upcoming Dividend of JP¥15.00 Per Share

New 90-day high - JP¥529

Art Vivant Co., Ltd. to Report Q2, 2021 Results on Nov 12, 2020

New 90-day high - JP¥513

First quarter earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven